ArticleBMC musculoskeletal disorders2025
Synovitis, acne, pustular lesions, hyperostosis, and osteitis syndrome associated with monoclonal gammopathy of undetermined significance: a case report.
Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Herein, we present a case of synovitis, acne, pustular lesions, hyperostosis, and osteitis (SAPHO) syndrome in which the patient had monoclonal gammopathy. To identify whether the patient had blood proliferative disorders, we performed bone marrow aspiration and positron emission tomography-computed tomography (PET-CT) examination. Finally, we diagnosed the patient with SAPHO syndrome and monoclonal gammopathy of undetermined significance (MGUS). The patient was followed up for two years with repeat bone marrow and PET-CT examinations, and no apparent disease progression or progression to another condition was observed. We concluded that SAPHO syndrome may coexist with monoclonal globulinemia; however, the pathogenesis of this combination remains unclear. This phenomenon should be closely monitored by clinicians to avoid misdiagnosis.In patients with SAPHO syndrome who present with MGUS, the diagnostic challenge lies in determining whether the bone pain symptoms are attributable to SAPHO syndrome itself or to the development of bone lesions due to the progression of MGUS to MM. When this rare condition arises, clinicians must exercise careful differentiation, ensuring neither its oversight nor its overdiagnosis as multiple myeloma (MM). CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.